• pagcor slot
  • pagcor slot online
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • tol777
  • slot tol777
  • rom88
  • slot rom88
  • Drug Pricing

    Commentary

    Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients.

    Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely. This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition ...
    Commentary

    Learn why drug price controls don't work

    The Expected Consequences Of Price Controls

    The intended consequence of the policy is to reduce overall spending on drugs, but all regulations have unintended consequences, too. While these consequences may be unintended, they need not be unexpected. In the case of the IRA, these unintended impacts now threaten to undermine the entire purpose of the policy. ...
    Commentary

    Learn why drug price controls don't work

    Don’t Buy Kamala Harris’ Anti-Price Gouging Plan

    That may sound like standard progressive fare. But the means by which she’d try to achieve those goals is a scheme of price controls that could destroy entire sectors of the U.S. economy. Read the full article at Forbes
    Commentary

    Read the latest on Biden administration's drug price controls

    Drug Price Controls Underperform, Unworkable

    According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
    Commentary

    Read the latest about the problems with PBMs

    Insulin Lawsuits Obscure A Dirty Business

    The plaintiffs say they’re fighting for patients. They’re less forthcoming about the fact that they’ve profited handsomely from the system they’re now decrying. For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers extract from drug makers when negotiating over ...
    Commentary

    Read the latest about VP Harris' healthcare platform

    Harris commits to worst of Biden healthcare policies

    One proposal Harris has explicitly backed would enshrine President Joe Biden’s enhanced Obamacare subsidies, which are slated to expire in 2025. “Republicans want to let those credits expire, increasing premiums,” the Democratic platform asserts. “Democrats will fight to make them permanent.” Read the full article at the Washington Examiner
    Commentary

    This Bipartisan Bill Would Upend America’s Pharmaceutical Industry

    Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market. Harris was the most progressive member of the Senate during ...
    Blog

    Read about Biden drug price control plan

    The Damage from Price Controls on Pharmaceuticals Begins

    The federal government has announced the long-awaited results from the 2022 Inflation Reduction Act’s (IRA) drug price negotiations.[1] The Biden Administration has been crowing that they have achieved “a historic moment that will help lower prescription drug prices for millions of people across America.” Nothing could be further from the ...
    Commentary

    Scope-of-practice laws put patients in the crosshairs

    New research appears to have found the proverbial “free lunch” economists have long been searching for. States that grant nurse practitioners “full practice authority” — that authorize them to provide care independently, without the supervision of a physician or other provider — reduce total healthcare costs for people with diabetes ...
    Commentary

    Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

    Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
    Commentary

    Drug Companies Are Embracing Direct-To-Consumer Sales. That’s A Win For Patients.

    Fortunately, that’s starting to change. In recent months, drug companies Pfizer and Eli Lilly have begun rolling out direct-to-consumer programs that let patients purchase basic prescriptions remotely. This development is a huge win for patients. Not only are direct-to-consumer offerings more convenient. They can also provide a jolt of competition ...
    Commentary

    Learn why drug price controls don't work

    The Expected Consequences Of Price Controls

    The intended consequence of the policy is to reduce overall spending on drugs, but all regulations have unintended consequences, too. While these consequences may be unintended, they need not be unexpected. In the case of the IRA, these unintended impacts now threaten to undermine the entire purpose of the policy. ...
    Commentary

    Learn why drug price controls don't work

    Don’t Buy Kamala Harris’ Anti-Price Gouging Plan

    That may sound like standard progressive fare. But the means by which she’d try to achieve those goals is a scheme of price controls that could destroy entire sectors of the U.S. economy. Read the full article at Forbes
    Commentary

    Read the latest on Biden administration's drug price controls

    Drug Price Controls Underperform, Unworkable

    According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
    Commentary

    Read the latest about the problems with PBMs

    Insulin Lawsuits Obscure A Dirty Business

    The plaintiffs say they’re fighting for patients. They’re less forthcoming about the fact that they’ve profited handsomely from the system they’re now decrying. For years, these cities and states have insisted on a cut—if not all—of the rebates that these pharmacy benefit managers extract from drug makers when negotiating over ...
    Commentary

    Read the latest about VP Harris' healthcare platform

    Harris commits to worst of Biden healthcare policies

    One proposal Harris has explicitly backed would enshrine President Joe Biden’s enhanced Obamacare subsidies, which are slated to expire in 2025. “Republicans want to let those credits expire, increasing premiums,” the Democratic platform asserts. “Democrats will fight to make them permanent.” Read the full article at the Washington Examiner
    Commentary

    This Bipartisan Bill Would Upend America’s Pharmaceutical Industry

    Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market. Harris was the most progressive member of the Senate during ...
    Blog

    Read about Biden drug price control plan

    The Damage from Price Controls on Pharmaceuticals Begins

    The federal government has announced the long-awaited results from the 2022 Inflation Reduction Act’s (IRA) drug price negotiations.[1] The Biden Administration has been crowing that they have achieved “a historic moment that will help lower prescription drug prices for millions of people across America.” Nothing could be further from the ...
    Commentary

    Scope-of-practice laws put patients in the crosshairs

    New research appears to have found the proverbial “free lunch” economists have long been searching for. States that grant nurse practitioners “full practice authority” — that authorize them to provide care independently, without the supervision of a physician or other provider — reduce total healthcare costs for people with diabetes ...
    Commentary

    Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

    Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
    Scroll to Top